-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ixabepilone in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ixabepilone in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ixabepilone in Peritoneal Cancer Drug Details: Ixabepilone (Ixempra, Ixemprya) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ixabepilone in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ixabepilone in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ixabepilone in Epithelial Ovarian Cancer Drug Details: Ixabepilone (Ixempra, Ixemprya)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tamibarotene in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tamibarotene in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tamibarotene in Acute Myelocytic Leukemia (AML,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tamibarotene in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tamibarotene in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tamibarotene in Refractory Acute Myeloid Leukemia Drug Details: Tamibarotene...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tamibarotene in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tamibarotene in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tamibarotene in Relapsed Acute Myeloid Leukemia Drug Details: Tamibarotene...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tamibarotene in Polycystic Kidney Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tamibarotene in Polycystic Kidney Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tamibarotene in Polycystic Kidney Disease Drug Details: Tamibarotene (Amnolake) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anamorelin Hydrochloride in Fatigue
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anamorelin Hydrochloride in Fatigue report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anamorelin Hydrochloride in Fatigue Drug Details: Anamorelin hydrochloride (Adlumiz) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lidocaine Hydrochloride in Neck Pain (Cervicalgia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lidocaine Hydrochloride in Neck Pain (Cervicalgia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lidocaine Hydrochloride in Neck Pain (Cervicalgia) Drug Details: Lidocaine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defactinib Hydrochloride in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defactinib Hydrochloride in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defactinib Hydrochloride in Fallopian Tube Cancer Drug Details: Defactinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Defactinib Hydrochloride in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Defactinib Hydrochloride in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Defactinib Hydrochloride in Peritoneal Cancer Drug Details: Defactinib hydrochloride (VS-6063)...